If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,784.00    -12.00 (-0.67%)
Bid:
1,786.00
Ask:
1,800.00
Spread: 14.00 (0.784%)
Market Cap: £525.42m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Post Close Trading Update

13 Oct 2021 07:00

RNS Number : 8651O
Avon Protection PLC
13 October 2021
 

13 October 2021

Avon Protection plc

Post Close Trading Update

 

Avon Protection plc ("Avon" or the "Group") today provides the following post close trading update for its financial year ended 30 September 2021 ("FY21").

 

Trading update

Avon has continued to see good commercial momentum in the second half of FY21, with order intake for the year of c.$280 million. This represents total year-on-year order growth of 34% and growth of 15% excluding Team Wendy. As a result, the Group has carried a strong closing order book of $141 million into the new financial year ("FY22"), up 39% on 30 September 2020. This momentum underpins confidence in the Group's growth expectations for FY22.

 

The Group expects to report revenue of $250 million for FY21 (2020: $213.6 million), which is within the range indicated in our trading update of 13 August 2021. This includes a Team Wendy contribution of $41 million from the first 11 months of ownership, in line with expectations at the time of acquisition.

 

As expected, we have seen revenue growth in our First Responder business and Military respiratory portfolio, offset by declines in Military ballistic revenue due to the previously announced delays. Overall, Military revenue is expected to decline by 3% to $149 million with respiratory revenue growth of 10% being offset by a 31% decline in Military ballistic revenues. First Responder revenues are expected to have increased by 2% to $61 million, against a strong comparator in 2020, driven by very encouraging growth in our ballistic protection portfolio.

 

Trading profitability in the remainder of FY21 was in line with the expectations set out in the August trading update. The Group will however recognise one-off, non-cash, ballistic protection inventory adjustments, which are expected to reduce the reported adjusted EBITDA margin for FY21 to between 15% and 16%.

 

Cash conversion has come through more strongly than anticipated at the time of the August trading update. As a result, we expect FY21 reported cash conversion of c.80% and net debt before lease liabilities of $27 million at 30 September 2021.

 

Commenting, Paul McDonald, Chief Executive Officer, said:

"We have made considerable commercial progress over the last 12 months in continuing to build a broader portfolio of contracts, increasing our pipeline of opportunities and making record levels of investment in the business.

 

We carry significant commercial momentum into FY22, which will also benefit from a strong ramp-up in body armor, as well as the strengthened senior management, processes and infrastructure we have put in place over the past year whilst navigating the ongoing disruption related to Covid through our supply chains.

 

We remain well set for growth in FY22 and beyond and are as confident as ever about the medium-term prospects of Avon Protection. This is underpinned by a strong order book, a growing and visible contract pipeline and our global market leading positions in respiratory and ballistic protection."

 

Notice of Results

The Group will release its results for the year ended 30 September 2021 on 23 November 2021.

 

For further enquiries, please contact:

 

Avon Protection plc

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Rachel Stevens, Director of Investor Relations

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Protection plc is listed on the London Stock Exchange (LSE: AVON) and is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website www.avon-protection-plc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETIDLFLIL
Date   Source Headline
10th Jul 20238:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
27th Jun 20235:00 pmRNSHolding(s) in Company
20th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:00 pmRNSHolding(s) in Company
6th Jun 20232:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20235:00 pmRNSHolding(s) in Company
30th May 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:00 pmRNSDirector/PDMR Shareholding
26th May 20233:00 pmRNSNotification of transaction of PDMR
26th May 20233:00 pmRNSNotification of transaction of PDMR and PCA
23rd May 20237:00 amRNSInterim Results
9th May 202310:00 amRNSDirector/PDMR Shareholding
11th Apr 202312:00 pmRNSDirector/PDMR Shareholding
7th Mar 20231:00 pmRNSDirector/PDMR Shareholding
21st Feb 20235:00 pmRNSFinal Dividend Currency Exchange Rate
9th Feb 20232:00 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSU.S. Defense Logistics Agency helmet order
8th Feb 202312:00 pmRNSDirector/PDMR Shareholding
27th Jan 20234:00 pmRNSResult of AGM
27th Jan 20237:00 amRNSAGM Trading Update
18th Jan 20233:00 pmRNSDirector/PDMR Shareholding
5th Jan 20234:00 pmRNSDirector/PDMR Shareholding
21st Dec 20224:00 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSHolding(s) in Company
8th Dec 20225:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:00 amRNSDirector/PDMR Shareholding
5th Dec 20223:00 pmRNSNotice of Annual Report and AGM
5th Dec 20227:00 amRNSSale of Armor Assets
1st Dec 20224:01 pmRNSHolding(s) in Company
1st Dec 20229:00 amRNSHolding(s) in Company
29th Nov 20222:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSPreliminary Results
9th Nov 202212:00 pmRNSDirector/PDMR Shareholding
17th Oct 20227:00 amRNSAppointment of Chief Executive Officer
17th Oct 20227:00 amRNSAppointment of Chief Executive Officer
6th Oct 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSCEO Succession Update
29th Sep 20227:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
22nd Sep 20227:00 amRNSHolding(s) in Company
7th Sep 20221:20 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSOrder announcement and trading update
17th Aug 202212:00 pmRNSInterim Dividend Currency Exchange Rate
16th Aug 202210:00 amRNSDirector/PDMR Shareholding
11th Jul 20221:00 pmRNSDirector/PDMR Shareholding
7th Jun 20223:00 pmRNSDirector/PDMR Shareholding
24th May 20227:00 amRNSInterim Results
9th May 20224:00 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTransaction in Own Shares
12th Apr 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.